Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07767253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

Name: Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD) — clinical trial record (NCT07767253)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2026-09

View on ClinicalTrials.gov ↗

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

Atopic Dermatitis

489 trials monitored

See 14 trials at risk

This study is a 2-part (parts A and B) study.The primary objective of the study is to evaluate the efficacy of 611 in Chinese Children with moderate to severe atopic dermatitis (AD).

Trial Details

NCT Number	NCT07767253
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Dermatitis, Atopic
Enrollment	246 participants
Start Date	2026-09
Primary Completion	2027-09 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-17